RMY Stock Chart & Stats
€26.00
€0.20(0.78%)
At close: 4:00 PM EDT
€26.00
€0.20(0.78%)
Day’s Range― - ―
52-Week Range€17.10 - €32.60
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€7.59B
Enterprise Value€21.28K
Total Cash (Recent Filing)€729.90M
Total Debt (Recent Filing)€11.00B
Price to Earnings (P/E)39.2
Beta0.66
Next Earnings
Mar 03, 2027EPS Estimate
0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.36
Shares Outstanding230,829,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)2.04
Price to Sales (P/S)0.54
P/FCF Ratio14.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€31.27Price Target Upside20.28% Upside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)1.1
Revenue Forecast (FY)€11.56B
Bulls Say, Bears Say
Bulls Say
Underlying Earnings GrowthBroad revenue and EBIT growth indicates continued demand for Ramsay’s hospital services and improving operating leverage. Sustained earnings expansion across the group can strengthen internal funding capacity and support investment in facilities and technology.
Australian Operating MomentumAustralia is the core operating engine, combining admission growth with improving margins. Planned theatres and cath labs, higher utilisation and technology-led productivity should expand capacity and support durable share gains in a large healthcare market.
Cash Generation And LiquidityStrong cash generation and substantial liquidity provide funding for capacity expansion while reducing reliance on external capital. Leverage below management’s target range and solid interest cover also improve resilience against operating volatility and financing demands.
Bears Say
Leverage And Earnings VolatilityA highly leveraged balance sheet limits financial flexibility, particularly when profitability is uneven. Volatile earnings and shareholder returns make deleveraging less predictable and could constrain acquisitions, dividends or investment during weaker operating periods.
European And UK Funding PressureFunding and reimbursement constraints in Europe create a persistent drag on group performance. Losses, high regional leverage and weak UK public activity may require restructuring or capital support, limiting the benefit of stronger Australian operations.
Persistent Cost And Financing PressuresMulti-year wage agreements and elevated financing costs can absorb a meaningful portion of revenue growth. These pressures may restrict margin expansion, especially where reimbursement rates or public tariffs cannot fully recover labour and funding inflation.
Ramsay Health Care News
RMY FAQ
What was Ramsay Health Care’s price range in the past 12 months?
Ramsay Health Care lowest stock price was €17.10 and its highest was €32.60 in the past 12 months.
What is Ramsay Health Care’s market cap?
Ramsay Health Care’s market cap is €7.59B.
When is Ramsay Health Care’s upcoming earnings report date?
Ramsay Health Care’s upcoming earnings report date is Mar 03, 2027 which is in 175 days.
How were Ramsay Health Care’s earnings last quarter?
Ramsay Health Care released its earnings results on Aug 26, 2026. The company reported €0.496 earnings per share for the quarter, beating the consensus estimate of €0.429 by €0.067.
Is Ramsay Health Care overvalued?
According to Wall Street analysts Ramsay Health Care’s price is currently Undervalued.
Does Ramsay Health Care pay dividends?
Ramsay Health Care does not currently pay dividends.
What is Ramsay Health Care’s EPS estimate?
Ramsay Health Care’s EPS estimate is 0.46.
How many shares outstanding does Ramsay Health Care have?
Ramsay Health Care has 230,829,800 shares outstanding.
What happened to Ramsay Health Care’s price movement after its last earnings report?
Ramsay Health Care reported an EPS of €0.496 in its last earnings report, beating expectations of €0.429. Following the earnings report the stock price went up 14.178%.
Which hedge fund is a major shareholder of Ramsay Health Care?
Currently, no hedge funds are holding shares in DE:RMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ramsay Health Care Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€31.27 (20.28% Upside)
€31.27 (20.28% Upside)
Blogger Sentiment
Neutral
DE:RMY Sentiment 50%
Sector Average 60%
Sector Average 60%
Insider Transactions
Sold Shares
Worth €30.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
63.84%
12-Months-Change
Fundamentals
Return on Equity
1.75%
Trailing 12-Months
Asset Growth
-2.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ramsay Health Care
Ramsay Health Care Limited is a prominent healthcare provider that manages and possesses hospitals. The company delivers medical services to both publicly funded and privately insured individuals. It maintains a substantial international presence, operating roughly 532 facilities across the Asia Pacific region, the United Kingdom, France, and the Nordic nations. Founded in 1964, its corporate headquarters are situated in Sydney, Australia.
RMY Company Deck
RMY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents strong operational and financial momentum driven by Australian transformation initiatives and Funding Group improvements — evidenced by double-digit underlying EBIT growth in Australia, broad regional EBIT growth, improved margins and cash generation, higher dividends, and successful cost and utilization measures. Offsetting these positives are notable challenges in Europe (Ramsay Santé funding headwinds and working capital/timing issues), restructure costs and demand weakness at Elysium, wage inflation pressures from multi-year EBAs, a remediation provision relating to a Fair Work decision, and increased interest costs. On balance the company demonstrates tangible progress on its strategic priorities and financial discipline while managing several region-specific headwinds.View all DE:RMY earnings summariesRMY Stock 12 Month Forecast
Average Price Target
€31.27
▲(20.28% Upside)
Technical Analysis
Healius Limited
―
Regis Healthcare Ltd.
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―